C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy

C-reactive protein in patients with advanced metastatic renal cell carcinoma: Usefulness in identifying patients most likely to benefit from initial nephrectomy

<p>Abstract</p> <p>Objective</p> <p>C-reactive protein (CRP) is considered a useful serum marker for patients with RCC. However, its clinical utility in advanced metastatic renal cell carcinoma (AM-RCC), particularly in deciding whether to perform nephrectomy at the ons...

Full description

Bibliographic Details
Main Authors: Ito Hiroki, Shioi Koichi, Murakami Takayuki, Takizawa Akitoshi, Sano Futoshi, Kawahara Takashi, Mizuno Nobuhiko, Makiyama Kazuhide, Nakaigawa Noboru, Kishida Takeshi, Miura Takeshi, Kubota Yoshinobu, Yao Masahiro
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BMC Cancer
Subjects:
C-reactive protein
Rena cell carcinoma
Prognosis
Online Access:http://www.biomedcentral.com/1471-2407/12/337

Similar Items

Similar Items